Brighter Capital

Brighter Capital is a US-based venture firm with a public footprint that signals an early-stage, generalist software mandate. Public disclosures on healthcare exposure, fund size, and check sizes are limited, so founders should treat them as a generalist seed-and-Series-A firm whose fit with healthcare AI depends on the specific business model rather than a stated thesis. Plausible check size is $500K to $2M based on typical small-fund seed economics. For healthcare AI founders, Brighter is most credible as a co-investor on software-flavored deals — RCM, scheduling, ambient documentation, payer ops, and provider workflow — where SaaS metrics and a clear US commercial story matter more than clinical or regulatory specialization. Stage focus is likely seed and early Series A. Founders who should approach: SaaS-shaped healthcare startups with traction, clear sales motion, and a need for a flexible co-investor to fill out a primary-led round. Founders who should not approach: regulated devices, biotech, and any team that needs deep healthcare-specialist diligence and follow-on capacity. The realistic entry path is a warm introduction through a portfolio founder or co-investor; their Crunchbase and LinkedIn pages provide a starting point for mapping the network. Cold outbound is feasible but lower-yield without a referrer. Be honest about what Brighter can and cannot do: they can fill a round, they cannot anchor a specialist healthcare cap table. If your round needs a domain lead, source the lead first and bring Brighter in as round-completion capital.